Lozada, Mary Joy R.
HRN: 02-88-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2023
CEFTRIAXONE 1G (VIAL)
06/10/2023
06/16/2023
IV
2gm
Q24
Tc Moderate Leptospirosis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes